Has Pawan Gundavaram received payments from drug or device companies?

Yes. Drug and device makers reported $11,408 in general payments to Pawan Gundavaram across 395 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Pawan Gundavaram did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Pawan Gundavaram come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Pawan Gundavaram

Hematology & Oncology · Roselle, NJNPI 1174717300

Payments from drug & device makers

$11,408in general payments, 2019–2025

Across 395 payments — averaging $28.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$3K
AstraZeneca$2K
Jazz Pharmaceuticals Inc.$1K
Incyte Corporation$582
Daiichi Sankyo Inc.$541
E.r. Squibb & Sons, L.L.C.$494
plus $4K from 38 others

What the payments were for

Consulting fees$2,46522%
Speaking & faculty fees$3503%
Food & beverage$5,06844%
Education$8537%
Gifts$1,47413%
Other$1,19811%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	58	$3,302
AstraZeneca(2 entities)	28	$1,763
Jazz Pharmaceuticals Inc.	3	$1,138
Incyte Corporation	23	$582
Daiichi Sankyo Inc.	57	$541
E.r. Squibb & Sons, L.L.C.	37	$494
Merck	30	$458
Athenex Pharmaceutical Division, LLC	2	$350
Amgen	14	$311
Pharmacyclics LLC, An Abbvie Company	6	$253
Seagen Inc.	16	$231
Astellas Pharma US Inc	6	$231
Gilead(2 entities)	13	$201
Pfizer	9	$162
Bristol Myers Squibb	10	$143
Bayer	8	$126
Takeda Pharmaceuticals U.S.A., Inc.	6	$105
Eisai Inc.	7	$97
GSK	6	$92
Johnson & Johnson	6	$91
Lilly USA, LLC	5	$74
Boehringer Ingelheim	5	$69
Sanofi	5	$67
Teva Pharmaceuticals USA, Inc.	4	$46
Exelixis Inc.	3	$40
Sirtex Medical Inc	2	$39
Mylan Institutional Inc.	3	$38
Ipsen Biopharmaceuticals, Inc	2	$37
AVEO Pharmaceuticals, Inc.	1	$33
Karyopharm Therapeutics Inc.	2	$30
Epizyme, Inc.	2	$28
Rigel Pharmaceuticals, Inc.	2	$28
Irhythm Technologies, Inc.	1	$28
TG Therapeutics, Inc.	2	$27
Array Biopharma Inc	2	$27
Secura Bio, Inc.	1	$17
Althera Pharmaceuticals LLC	1	$16
Fortovia Therapeutics, Inc.	1	$15
Genentech USA, Inc.	1	$15
AMAG Pharmaceuticals, Inc.	1	$14
Tolmar Pharmaceuticals, Inc.	1	$13
Global Blood Therapeutics, Inc.	1	$13
Puma Biotechnology, Inc.	1	$11
AbbVie	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

KISQALI$1,351
ZEPZELCA$1,100

How this compares

$11,408 in reported general payments places this provider in the 55th percentile of 362 hematology & oncology providers in New Jersey.

See all hematology & oncology providers in New Jersey →

Other hematology & oncology in Roselle

Bruno FangEast Brunswick$8.5M
Charles FarberMorristown$4.6M
Rajat BannerjiNew Brunswick$3.3M
Eleonora TeplinskyParamus$2.6M
Mohamad CherryMorristown$1.9M
Evan NaylorManahawkin$1.3M
James OrsiniBelleville$1.3M
Eli KirshnerWestwood$1.2M
Linda DanieuLivingston$1.2M
Steven PapishMorristown$1.2M

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →